Chargement en cours...
Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy
We present 2 patients with metastatic colorectal cancer who had progressed despite treatment with first-line FOLFOX and second-line FOLFIRI combination chemotherapy regimens. After failing these fluoropyrimidine-based regimens, both patients received additional cytotoxic and targeted therapies with...
Enregistré dans:
| Publié dans: | Cancer Biol Ther |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847811/ https://ncbi.nlm.nih.gov/pubmed/26561209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1113355 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|